Results 221 to 230 of about 627,120 (277)
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor +2 more
wiley +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Checkpoint blockade and the stem‐like T cell trade‐off
Stem‐like T cells are key to the success of programmed cell death protein 1 (PD1) blockade, as they sustain long‐term anti‐tumor response by continuously generating effector CD8+ T cells. However, how these cells are maintained in cancer is not fully understood. Hor et al.
Julie M. Mazet, Johanna A. Joyce
wiley +1 more source
Molecular cancer prevention: Intercepting disease
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Toward multimode-fiber shape sensing
Optics Letters, 2023We demonstrate machine-learning assisted dynamic tracking of the shape of a multimode fiber whose spatial configuration is manipulated by the movement of three linear stages. The data source used for the analysis is the coherent speckle pattern of light that has made a round trip in the fiber.
Barak Hadad +4 more
openaire +2 more sources
Multimode Waveguide Shape Sensing
28th International Conference on Optical Fiber Sensors, 2023Optical fiber shape sensing are important measurement technologies in applications such as healthcare, structural monitoring and robotics. Current state-of-the-art optical fiber shape sensing requires complex sensor structures and interrogation systems.
Xuechun Wang +3 more
openaire +1 more source
The mechanical forces that shape our senses
Development, 2022ABSTRACTDeveloping organs are shaped, in part, by physical interaction with their environment in the embryo. In recent years, technical advances in live-cell imaging and material science have greatly expanded our understanding of the mechanical forces driving organ formation.
Anh Phuong Le, Jin Kim, Karl R. Koehler
openaire +2 more sources
From Sensing Shape to Shaping Sense: A Dynamic Model of Absorptive Capacity and Selective Revealing
SSRN Electronic Journal, 2011The concept of absorptive capacity is mainly agnostic to the iterative nature of knowledge production processes.
ALEXY, Oliver +2 more
openaire +2 more sources

